Co-chairs Jeff Lazarus and Jörn Schattenberg of the Innovations in NAFLD Care 2022 Series join the Surfers to review the initiative’s key elements and patient awareness goals.
Co-chairs of the Innovations in NAFLD Care 2022 initiative join the Surfers to review the initiative’s goals and agenda.
Jeff Lazarus and Jörn Schattenberg join the Surfers to discuss their new Innovations in NAFLD Care 2022 webinar and hybrid meeting series in a session whose dialogue blends medical, economic and public health discussions.
Donna Cryer and Scott Friedman share perspectives on where all things NASH and NAFLD are heading in a conversation with Roger Green.
First-timers Amy Articolo (Novo Nordisk), Erin Quirk (Terns Pharmaceuticals) and Rachel Zayas (AGED Diagnostics) join the Surfers and guest KOL Ian Rowe to explore what NASH-TAG 2022 taught us about improving clinical trial efficiency by reducing screen fail rates.
First-timers Amy Articolo (Novo Nordisk), Erin Quirk (Terns Pharmaceuticals) and Rachel Zayas (AGED Diagnostics) join the Surfers and guest KOL Ian Rowe to explore messages for patients and regulators from the firecis NASH-TAG 2022.
First-timers Amy Articolo (Novo Nordisk), Erin Quirk (Terns Pharmaceuticals) and Rachel Zayas (AGED Diagnostics) join the Surfers and guest KOL Ian Rowe to discuss key takeaways from the fireside chats that closed NASH-TAG 2022.
First-timers Amy Articolo (Novo Nordisk), Erin Quirk (Terns Pharmaceuticals), and Rachel Zayas (AGED Diagnostics) join the Surfers and guest KOL Ian Rowe to identify the highest impact presentations and messages of NASH-TAG 2022.
NASH-TAG 2022 Wrap-Up: Finding New Disease Insights and Reconsidering Clinical Trial Design
The Surfers and “fifth Beatle” Jörn Schattenberg review the highs, lows and powerful moments of Day Two at NASH-TAG 2022.
